Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancers|January 15, 2021
A Paravermal Trans-Cerebellar Approach to the Posterior Fossa Tumor Causes Hypertrophic Olivary Degeneration by Dentate Nucleus InjuryMartin A Schaller-Paule, Peter Baumgarten, Volker Seifert, et al.
Clinical Neuroradiology|November 23, 2022
Topographic Mapping of Isolated Thalamic Infarcts Using Vascular and Novel Probabilistic Functional Thalamic LandmarksMaximilian Rauch, Jan-Rüdiger Schüre, Franziska Lieschke, et al.
Oncology|January 20, 2021
Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III GliomasIris Divé, Eike Steidl, Marlies Wagner, et al.
Journal of Cancer Research and Clinical Oncology|February 4, 2021
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapyEike Steidl, Katharina Filipski, Pia S Zeiner, et al.
Frontiers in Neurology|August 2, 2021
Multicenter Prospective Analysis of Hypertrophic Olivary Degeneration Following Infratentorial Stroke (HOD-IS): Evaluation of Disease Epidemiology, Clinical Presentation, and MR-Imaging AspectsMartin A Schaller-Paule, Eike Steidl, Manoj Shrestha, et al.
Frontiers in Immunology|January 20, 2022
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and CategorizationHans Urban, Eike Steidl, Elke Hattingen, et al.
Neuro-Oncology Advances|November 29, 2023
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastomaIris Divé, Katharina J Weber, Tabea I Hartung, et al.
Journal of Clinical Medicine|November 27, 2019
Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma PatientsPia S Zeiner, Martina Kinzig, Iris Divé, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 26, 2020
Sequential implementation of DSC-MR perfusion and dynamic [<sup>18</sup>F]FET PET allows efficient differentiation of glioma progression from treatment-related changesEike Steidl, Karl-Josef Langen, Sarah Abu Hmeidan, et al.
Immunity|October 22, 2025
Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structuresPinar Cakmak, Jennifer H Lun, Aakanksha Singh, et al.
Pageof 3